Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Washington University School of Medicine
Washington University School of Medicine
National Cancer Institute (NCI)
Duke University
National Institutes of Health Clinical Center (CC)